List of Active Biotech AB patents

Patents where

Current Assignee

Name

‌

Active Biotech AB

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7189816 Compounds	Patent 7189816 was granted and assigned to Active Biotech AB on March, 2007 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7189816	March 13, 2007
‌ US Patent 7425623 Antibody with specificity for colon cancer	Patent 7425623 was granted and assigned to Active Biotech AB on September, 2008 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7425623	September 16, 2008
‌ US Patent 11478465 Compounds for treatment of eye diseases associated with excessive vascularisation		‌ Active Biotech AB	‌ Active Biotech AB	United States Patent and Trademark Office	11478465	October 25, 2022
‌ US Patent 7226601 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate	Patent 7226601 was granted and assigned to Active Biotech AB on June, 2007 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7226601	June 5, 2007
‌ US Patent 7615225 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen	Patent 7615225 was granted and assigned to Active Biotech AB on November, 2009 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7615225	November 10, 2009
‌ US Patent 7589208 Compositions containing quinoline compounds	Patent 7589208 was granted and assigned to Active Biotech AB on September, 2009 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7589208	September 15, 2009
‌ US Patent 9771372 Compounds useful as S100-inhibitors	Patent 9771372 was granted and assigned to Active Biotech AB on September, 2017 by the United States Patent and Trademark Office.	‌ Active Biotech AB	‌ Active Biotech AB	United States Patent and Trademark Office	9771372	September 26, 2017
‌ US Patent 7674906 Tetracyclic immunomodulatory compounds	Patent 7674906 was granted and assigned to Active Biotech AB on March, 2010 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7674906	March 9, 2010
‌ US Patent 7511143 Compositions containing quinoline compounds	Patent 7511143 was granted and assigned to Active Biotech AB on March, 2009 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7511143	March 31, 2009
‌ US Patent 10385069 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors	Patent 10385069 was granted and assigned to Active Biotech AB on August, 2019 by the United States Patent and Trademark Office.	‌ Active Biotech AB	‌ Active Biotech AB	United States Patent and Trademark Office	10385069	August 20, 2019
‌ US Patent 7560557 Process for the manufacture of quinoline derivatives	Patent 7560557 was granted and assigned to Active Biotech AB on July, 2009 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7560557	July 14, 2009
‌ US Patent 9873687 N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors	Patent 9873687 was granted and assigned to Active Biotech AB on January, 2018 by the United States Patent and Trademark Office.	‌ Active Biotech AB	‌ Active Biotech AB	United States Patent and Trademark Office	9873687	January 23, 2018
‌ US Patent 10314836 Quinoline carboxamides for use in the treatment of multiple myeloma	Patent 10314836 was granted and assigned to Active Biotech AB on June, 2019 by the United States Patent and Trademark Office.	‌ Active Biotech AB	‌ Active Biotech AB	United States Patent and Trademark Office	10314836	June 11, 2019
‌ US Patent 7553849 Compounds	Patent 7553849 was granted and assigned to Active Biotech AB on June, 2009 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7553849	June 30, 2009
‌ US Patent 7339059 Benzofurans and indols	Patent 7339059 was granted and assigned to Active Biotech AB on March, 2008 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7339059	March 4, 2008
‌ US Patent 9956212 Quinoline carboxamides for use in the treatment of multiple myeloma	Patent 9956212 was granted and assigned to Active Biotech AB on May, 2018 by the United States Patent and Trademark Office.	‌ Active Biotech AB	‌ Active Biotech AB	United States Patent and Trademark Office	9956212	May 1, 2018
‌ US Patent 9216956 Deuterium-enriched 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide	Patent 9216956 was granted and assigned to Active Biotech AB on December, 2015 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	9216956	December 22, 2015
‌ US Patent 7763253 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent	Patent 7763253 was granted and assigned to Active Biotech AB on July, 2010 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7763253	July 27, 2010
‌ US Patent 8871936 Method for manufacturing of quinoline-3-carboxamides	Patent 8871936 was granted and assigned to Active Biotech AB on October, 2014 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	8871936	October 28, 2014
‌ US Patent 8754104 Crystalline salts of quinoline compounds and methods for preparing them		‌ Active Biotech AB	‌ Active Biotech AB	United States Patent and Trademark Office	8754104	June 17, 2014
‌ US Patent 7125554 Engineered superantigen for human therapy	Patent 7125554 was granted and assigned to Active Biotech AB on October, 2006 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7125554	October 24, 2006
‌ US Patent 10300053 Quinoline carboxamides for use in the treatment of leukemia	Patent 10300053 was granted and assigned to Active Biotech AB on May, 2019 by the United States Patent and Trademark Office.	‌ Active Biotech AB	‌ Active Biotech AB	United States Patent and Trademark Office	10300053	May 28, 2019
‌ US Patent 7291612 Immunomodulatory compounds	Patent 7291612 was granted and assigned to Active Biotech AB on November, 2007 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	7291612	November 6, 2007
‌ US Patent 8841421 S100A9 interaction screening method	Patent 8841421 was granted and assigned to Active Biotech AB on September, 2014 by the United States Patent and Trademark Office.		‌ Active Biotech AB	United States Patent and Trademark Office	8841421	September 23, 2014
‌ US Patent 10125125 N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors	Patent 10125125 was granted and assigned to Active Biotech AB on November, 2018 by the United States Patent and Trademark Office.	‌ Active Biotech AB	‌ Active Biotech AB	United States Patent and Trademark Office	10125125	November 13, 2018

Results per page:

31 results

0 selected

31 results

0 selected